Corrado Barbui

Active 1997–2025

159
Papers
26,676
Citations
78
h-index
148
i10-index

Citations

Citations per year for Corrado Barbui1999: 1 citations2000: 1 citations2001: 4 citations2002: 8 citations2003: 13 citations2004: 12 citations2005: 38 citations2006: 34 citations2007: 66 citations2008: 45 citations2009: 105 citations2010: 96 citations2011: 108 citations2012: 139 citations2013: 177 citations2014: 165 citations2015: 196 citations2016: 163 citations2017: 205 citations2018: 174 citations2019: 647 citations2020: 767 citations2021: 848 citations2022: 709 citations2023: 534 citations2024: 1,019 citations2025: 482 citations2026: 25 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,070 citing papers, 16.2% of this breakdownUnited Kingdom: 1,451 citing papers, 11.4% of this breakdownGermany: 753 citing papers, 5.9% of this breakdownChina: 723 citing papers, 5.7% of this breakdownItaly: 713 citing papers, 5.6% of this breakdownCanada: 627 citing papers, 4.9% of this breakdownAustralia: 531 citing papers, 4.2% of this breakdownNetherlands: 428 citing papers, 3.4% of this breakdownSwitzerland: 368 citing papers, 2.9% of this breakdownSpain: 350 citing papers, 2.7% of this breakdownSweden: 279 citing papers, 2.2% of this breakdownJapan: 275 citing papers, 2.2% of this breakdown
0%16.2%Other 32.7%

Fields

  • Medicine59.5%
  • Psychology18.1%
  • Neuroscience9%
  • Biochemistry, Genetics and Molecular Biology3.3%
  • Health Professions3%
  • Decision Sciences1.2%
  • Other5.9%

Topics

  • Schizophrenia research and treatment6%
  • Treatment of Major Depression4.3%
  • Liver Disease Diagnosis and Treatment3.5%
  • Bipolar Disorder and Treatment2.7%
  • Tryptophan and brain disorders2.6%
  • Mental Health Treatment and Access2.5%
  • Other78.4%

Coauthors

All papers

Open in search
  1. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

    Authors: , , , , - Journal of Hepatology 2016 cited by 1,410

  2. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet Psychiatry 2018 cited by 1,333

  3. Imputing missing standard deviations in meta-analyses can provide accurate results

    Authors: , , , , - Journal of Clinical Epidemiology 2005 cited by 1,561

  4. Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis

    Authors: , , , , , , , , , , , , , , , , - The Lancet 2022 cited by 413

  5. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

    Authors: , , , , , , , , , , , , , , - The Lancet 2013 cited by 2,537

  6. Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jae Il Shin, Elena Dragioti - BMJ 2023 cited by 245

  7. Reducing the Risk of Cognitive Decline and Dementia: WHO Recommendations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Frontiers in Neurology 2022 cited by 201

  8. Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - World Psychiatry 2023 cited by 140

  9. Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials

    Authors: , , , , , , , , - Journal of Affective Disorders 2015 cited by 393

  10. Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis

    Authors: , , , , , , , , , , , , , , , - PLoS Medicine 2020 cited by 342

  11. Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality

    Authors: , , , , - JAMA Network Open 2024 cited by 88

  12. Efficacy of psychosocial interventions for mental health outcomes in low-income and middle-income countries: an umbrella review

    Authors: , , , , , , , , , , , , , , , , , - The Lancet Psychiatry 2020 cited by 341

  13. Psychosocial and psychological interventions for relapse prevention in schizophrenia: a systematic review and network meta-analysis

    Authors: , , , , , , , , , , , , - The Lancet Psychiatry 2021 cited by 265

  14. Oral and long‐acting antipsychotics for relapse prevention in schizophrenia‐spectrum disorders: a network meta‐analysis of 92 randomized trials including 22,645 participants

    Authors: , , , , , , , , , , , , - World Psychiatry 2022 cited by 115

  15. Imputing response rates from means and standard deviations in meta-analyses

    Authors: , , , , - International Clinical Psychopharmacology 2004 cited by 350

  16. Psychological and Psychosomatic Symptoms of Second Victims of Adverse Events: a Systematic Review and Meta-Analysis

    Authors: , , , , , - Journal of Patient Safety 2019 cited by 232

  17. Risk factors of postpartum depression and depressive symptoms: umbrella review of current evidence from systematic reviews and meta-analyses of observational studies

    Authors: , , , , - The British Journal of Psychiatry 2022 cited by 141

  18. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

    Authors: , , , , , , , , , , , - The Lancet 2009 cited by 1,656

  19. Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System

    Authors: , , , , - Psychotherapy and Psychosomatics 2020 cited by 131

  20. An umbrella review of candidate predictors of response, remission, recovery, and relapse across mental disorders

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Molecular Psychiatry 2023 cited by 68

  21. Pharmacotherapy for post-traumatic stress disorder: Systematic review and meta-analysis

    Authors: , , , , , , , , , , - The British Journal of Psychiatry 2015 cited by 410

  22. Psychological interventions to reduce positive symptoms in schizophrenia: systematic review and network meta‐analysis

    Authors: , , , , , , , , , , , - World Psychiatry 2018 cited by 197

  23. Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database

    Authors: , , , , , , , , , , - Drug Safety 2022 cited by 57

  24. COVID-19 and common mental health symptoms in the early phase of the pandemic: An umbrella review of the evidence

    Authors: , , , , , , , , , , , , , , , , , , - PLoS Medicine 2023 cited by 136